Accordant Advisory Group’s Pfizer PFE Stock Holding History

Accordant Advisory Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.61K	Hold	150	–	–	﹤0.01%	193
2026 Q1	$4.21K	Buy	+150	New	+$3.99K	﹤0.01%	191

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Accordant Advisory Group's PFE Position: Q2 2026 in Review

Accordant Advisory Group held its Pfizer (PFE) position steady in Q2 2026 at 150 shares worth $3.61K. The position accounts for ﹤0.01% of the portfolio, ranked #193.

Accordant Advisory Group first reported a position in PFE in Q1 2026 and has held it in 2 quarters since. The position peaked at $4.21K in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Accordant Advisory Group held 150 shares of Pfizer worth $3.61K as of Q2 2026.
Accordant Advisory Group left its Pfizer share count unchanged in Q2 2026.
Pfizer made up ﹤0.01% of Accordant Advisory Group's portfolio in Q2 2026, its #193 holding.
Accordant Advisory Group first reported a position in Pfizer in Q1 2026 and has held it in 2 quarters since.
Accordant Advisory Group's Pfizer position peaked at $4.21K in Q1 2026.
2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Accordant Advisory Group's 13F filing for Q2 2026, filed 27 Jul 2026.